Quest Diagnostics (DGX) Net Income towards Common Stockholders Growth (5y) (2014 - 2026)
Quest Diagnostics (DGX) Net Income towards Common Stockholders Growth (5y) (2014 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn |
| 10 | Quest Diagnostics | 22.46 Bn | 22.36 Bn | 942.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.92% |
| Dec 31, 2025 | 44.32% |
| Sep 30, 2025 | 46.08% |
| Jun 30, 2025 | 47.58% |
| Mar 31, 2025 | 43.10% |
| Dec 31, 2024 | 44.32% |
| Sep 30, 2024 | 43.39% |
| Jun 30, 2024 | 54.14% |
| Mar 31, 2024 | 39.04% |
| Dec 31, 2023 | 38.93% |
| Sep 30, 2023 | 43.20% |
| Jun 30, 2023 | 48.00% |
| Mar 31, 2023 | 46.87% |
| Dec 31, 2022 | -19.37% |
| Sep 30, 2022 | 12.04% |
| Jun 30, 2022 | 5.02% |
| Mar 31, 2022 | 17.63% |
| Dec 31, 2021 | 66.79% |
| Sep 30, 2021 | 75.97% |
| Jun 30, 2021 | 89.65% |